XMVM - ETF AI Analysis
Top Page
Invesco S&P MidCap Value with Momentum ETF (XMVM)
XMVM’s rating suggests it is a solid but not top-tier ETF, with its performance driven largely by strong, diversified holdings in companies like Renaissancere Holdings and Tenet Healthcare, which show robust earnings, effective capital management, and positive growth outlooks. However, weaker names such as PBF Energy and Arrow Electronics, which face financial and cash flow challenges and bearish technical trends, hold back the overall score. The main risk factor is the fund’s exposure to several companies with profitability and cash flow pressures, which could add volatility even as momentum and value characteristics support the ETF’s quality.
XMVM vs. SPDR S&P 500 ETF (SPY)
- AUM
- 517.42M
- Region
- North America
- Expense Ratio
- 0.37%
- Beta
- 0.71
- Issuer
- Invesco
- Inception Date
- Mar 03, 2005
- Dividend Yield
- 1.87%
- Asset Class
- Equity
- Index Tracked
- S&P Midcap 400 High Momentum Value Index
XMVM Summary
The Invesco S&P MidCap Value with Momentum ETF (XMVM) tracks the S&P MidCap 400 High Momentum Value Index, focusing on medium‑sized U.S. companies that look cheap based on fundamentals and whose stock prices have been rising. It holds a mix of sectors, with a lot in financial, energy, and consumer companies, including well-known names like Macy’s and AutoNation. Investors might consider XMVM for growth potential from mid-sized companies plus diversification beyond large caps. A key risk is that mid-cap stocks and momentum strategies can be more volatile, so the ETF’s value can move up and down sharply with the market.
How much will it cost me?
The Invesco S&P MidCap Value with Momentum ETF (XMVM) has an expense ratio of 0.39%, which means you’ll pay $3.90 per year for every $1,000 invested. This cost is slightly higher than average for ETFs because it is actively managed, combining value and momentum strategies to select stocks. It aims to provide enhanced returns by targeting undervalued mid-cap companies with strong price momentum.
What would affect this ETF?
XMVM, with its focus on U.S. mid-cap value stocks and momentum strategies, could benefit from economic growth and favorable conditions for mid-sized companies, such as increased consumer spending or supportive financial sector trends. However, it may face challenges from rising interest rates, which could pressure financial stocks, and economic slowdowns that impact consumer cyclical sectors. Regulatory changes or shifts in market sentiment toward value or momentum investing could also influence its performance.
XMVM Top 10 Holdings
XMVM is leaning heavily into U.S. mid-cap value names with a clear tilt toward energy and financials. PBF Energy and HF Sinclair have been rising, giving the fund a strong tailwind from the energy patch, while industrial tech distributors like Avnet and Arrow Electronics are steadily adding support. On the flip side, consumer names such as Macy’s and Lear have seen more mixed, recently lagging action, occasionally acting as a brake on performance. Overall, the ETF is driven by cyclical, value-oriented U.S. companies rather than flashy Big Tech leaders.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| PBF Energy | 4.86% | $25.47M | $9.84B | 190.59% | 55Neutral | |
| HF Sinclair Corporation | 3.16% | $16.58M | $22.12B | 145.45% | 68Neutral | |
| Macy's | 2.38% | $12.46M | $6.16B | 28.45% | 74Outperform | |
| Penske Automotive Group | 2.09% | $10.93M | $13.92B | 23.80% | 71Outperform | |
| Tenet Healthcare | 2.12% | $11.09M | $21.45B | 33.00% | 74Outperform | |
| Renaissancere Holdings | 2.02% | $10.61M | $14.61B | 44.75% | 78Outperform | |
| Avnet | 1.88% | $9.86M | $7.49B | 78.58% | 67Neutral | |
| Arrow Electronics | 1.77% | $9.27M | $11.01B | 74.82% | 64Neutral | |
| Greif Class A | 1.77% | $9.27M | $4.38B | 35.46% | 67Neutral | |
| CNX Resources | 1.72% | $9.02M | $5.28B | 9.98% | 64Neutral |
XMVM Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For XMVM, the sentiment is Positive. The current price of 72.75 is above the 20-day moving average (MA) of 71.45, below the 50-day MA of 73.06, and above the 200-day MA of 69.31, indicating a neutral trend. The MACD of -0.12 indicates Negative momentum. The RSI at 54.75 is Neutral, neither overbought nor oversold. The STOCH value of 75.08 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for XMVM.
XMVM Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $72.75 | $80.00(9.97% Upside) | $517.42M | 0.37% | 71Outperform | |
| $79.11 | $93.53(18.23% Upside) | $789.29M | 0.20% | 71Outperform | |
| $44.53 | $50.41(13.19% Upside) | $442.32M | 0.31% | 69Neutral | |
| $146.58 | $168.60(15.02% Upside) | $334.06M | 0.35% | 68Neutral | |
| $17.48 | $20.72(18.49% Upside) | $284.27M | 0.55% | 67Neutral | |
| $62.03 | $73.37(18.28% Upside) | $229.91M | 0.74% | 70Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| XMVM | Invesco S&P MidCap Value with Momentum ETF | 72.75 | 14.12 | 24.07% | |
| AVMV | Avantis U.S. Mid Cap Value ETF | 79.11 | 11.25 | 16.58% | |
| NUMV | Nuveen ESG Mid-Cap Value ETF | 44.53 | 6.27 | 16.38% | |
| RFV | Invesco S&P Midcap 400 Pure Value ETF | 146.58 | 19.63 | 15.46% | |
| TMVE | Thrivent Mid Cap Value ETF | 17.48 | 3.23 | 22.64% | |
| FNK | First Trust Mid Cap Value AlphaDEX Fund | 62.03 | 8.15 | 15.12% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.